Pharmacy Examining Board

The Pharmacy Examining Board is created under Wis. Stat. § 15.405(9), and has authority as outlined in Wis. Stat. ch. 450.


Members

The members of the Pharmacy Examining Board are appointed by the Governor and confirmed by the Legislature to serve 4-year terms. The Board consists of 5 licensed pharmacist members and 2 public members. 

MemberOfficerMember TypeTerm Expiration
Schumacher, Thaddeus J.ChairpersonPharmacist Member7/1/2019
Trapskin, Philip J.Vice ChairpersonPharmacist Member7/1/2021
LaDien, Franklin (Rocky)SecretaryPharmacist Member7/1/2020
​Degner, GracePublic Member​7/1/2018
Maves, TerryPharmacist Member​7/1/2018
​Sullivan, KristiPublic Member​7/1/2020
Winters, Cathy J.Pharmacist Member​7/1/2021

*Board members whose terms have expired may continue to serve until their successor is confirmed by the Senate.


Important Information


U.S. Food and Drug Administration's lists of all currently approved interchangeable biological products.


Announcements


The 2017 Quarter 4 ePDMP Report is now available.

   2017 Quarter 4 e PDMP Report


Effective November 1, 2017, Phar 6 Has Been Updated Per 2017 Wisconsin Act 18

Phar 6 - Pharmacy Licenses and Equipment

2017 Wisconsin Act 18



Effective November 1, 2017, Phar 14 Has Been Updated

Phar 14 - Home Medical Oxygen Providers



Effective September 1, 2017, Phar 7.10 Has Been Updated

Phar 7.10 - Administration of drug products and devices other than vaccines



​On October 1, 2016 the following Pharmacy Chapters were updated:


Orders

Phar 1, 8 Relating to Definitions and Controlled Substances

Phar 1, 2 and 4 Relating to Application and Examination

Phar 5 Relating to Renewal and Reinstatement

Phar 8 Relating to Identification Card Required for Certain Controlled Substances




2015 Act 313 went into effect on April 1, 2016.  This Act no longer authorizes the Pharmacy Board to grant variances unless a disaster or emergency exists, but to instead institute pilot projects.  The Board is currently engaged in the transitioning of current non-emergency variances into pilot projects. Please see the link for more detailed information as to the Statutory requirements.

http://docs.legis.wisconsin.gov/document/statutes/450/02/3r




​CSB 4.04(2)(p) goes into effect on April 9, 2017.  This requires that the name recorded under s. 450.11(1b)(bm), Stats. be submitted to the Prescription Drug Monitoring Program.




​2015 Act 291 relating to prescription fills and refills went into effect on April 1, 2016. 




Please review the following update:

NTSB Information on Risk of Pilot Impairment




​As of September 1, 2014, Phar 8.05(4), 8.07(2) and 8.09 were amended to allow electronic prescriptions for
schedule II controlled substances.




​On August 28, 2014 the DEA published its final rule in the Federal Register placing Suvorexant into Schedule IV of the Federal Controlled Substances Act. The scheduling action was effective September 29, 2014. The Wisconsin Controlled Substances Board pursuant to s. 961.11(4), Stats took affirmative action to treat Suvorexant as a Schedule IV effective November 1, 2014.




On August 22, 2014 the DEA published its final rule in the Federal Register rescheduling hydrocodone combination products from Schedule III to Schedule II of the Federal Controlled Substances Act. The scheduling action was effective October 6, 2014. The Wisconsin Controlled Substances Board pursuant to s. 961.11(4), Stats took affirmative action to similarly reschedule hydrocodone combination products from Schedule III to Schedule II effective November 1, 2014.




​On July 2, 2014, the DEA published its final rule in the Federal Register placing tramadol into schedule IV of the federal Controlled Substances Act effective August 18, 2014. The Wisconsin Controlled Substances Board pursuant to s. 961.11(4), Stats took affirmative action to similarly treat tramadol as a schedule IV controlled substance​​​​​​​​ effective September 1, 2014.




​As of November 1, 2013, Phar 7.01(1)(e), Wis. Admin. Code, relating to delivery, became effective.




Last updated: 2/9/2018